A biodegradable copolyester, poly(Butylene succinate-co-e-caprolactone), as a high efficiency matrix former for controlled release of drugs
Visualitza/Obre
10.3390/pharmaceutics13071057
Inclou dades d'ús des de 2022
Cita com:
hdl:2117/358265
Tipus de documentArticle
Data publicació2021-07-01
Condicions d'accésAccés obert
Llevat que s'hi indiqui el contrari, els
continguts d'aquesta obra estan subjectes a la llicència de Creative Commons
:
Reconeixement-NoComercial-SenseObraDerivada 4.0 Internacional
Abstract
A biodegradable copolyester, poly(butylene succinate-co-e-caprolactone) (PBS_CL), was used for first time as an excipient for pharmaceutical dosage forms using direct compression and hot processing techniques (ultrasound-assisted compression (USAC) and hot melt extrusion (HME)). Robust binary systems were achieved with hot processing techniques, allowing a controlled release of the drug. With only 12% v/v of PBS_CL, controlled release forms were obtained using USAC whereas in HME over 34% v/v of excipient is necessary. Amounts over 23% v/v allowed a long-extended release for more than 72 h following diffusional kinetic. Thanks to the high melting point of theophylline and the physicochemical properties of PBS_CL selected and synthesized, the structure of the excipient inside the USAC tablets and HME filaments corresponds to a continuum medium. A percolation threshold around 23% v/v was estimated, which agrees with a continuum percolation model. The polymer shows a high excipient efficiency value using HME and USAC. A nanostructured matrix with wall thicknesses lower than 0.1 µm was obtained. This leads to a very effective coating of the drug particles by the excipient, providing a slow and reproducible release. The present study therefore supports the use of PBS_CL, for the preparation of controlled release dosage forms using hot processing techniques.
CitacióGaldón, E. [et al.]. A biodegradable copolyester, poly(Butylene succinate-co-e-caprolactone), as a high efficiency matrix former for controlled release of drugs. "Pharmaceutics", 1 Juliol 2021, vol. 13, núm. 7, p. 1057:1-1057:15.
ISSN1999-4923
Versió de l'editorhttps://www.mdpi.com/1999-4923/13/7/1057
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
pharmaceutics-13-01057(1).pdf | Articulo final "open access" | 2,209Mb | Visualitza/Obre |